What's new

Generic and hybrid applications

Generic and hybrid applications

Feb 19, 2025 - 11:15
 0
Generic and hybrid applications
Generic and hybrid applications
Read More

Tags:

Previous Article

Unite calls for urgent reforms to EV sales rules to protect jobs

Next Article

Biosimilar medicines: marketing authorisation

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Ervebo, Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations;Vaccines, PIP number: P/0495/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 09:00 (CET) to 11 December 2024, 10:30 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0